But while its overall profits and revenue beat Wall Street expectations, it slightly missed projections for its ...
Tata Motors shares react to Q3FY25 profit slump with mixed brokerage reviews. Explore target price insights from CLSA, GS, ...
Bajaj Healthcare has received an approval from the Drug Controller General of India (DCGI) to manufacture both the API and Drug Formulation of Pimavanserin, a 34 mg capsule.
Domestic markets saw further gains on Wednesday, continuing their recovery from Monday’s downturn, with broader mid and small ...
Larsen & Toubro, Adani Enterprises, Adani Ports and Special Economic Zone, Bajaj Finserv, Shree Cement, GAIL (India), Bank of Baroda, PB Fintech, AAVAS Financiers, Astral, Bharat Electronics, Biocon, ...
Adani Enterprises reported a rise in profit in Q3 FY24. The company posted a 2.3 times year-on-year (YoY) jump in consolidtaed net profit.